Humanigen signs manufacturing deal with Emergent for experimental COVID-19 drug
Shares of Humanigen Inc. were down 2.5% in trading on Monday after it announced a contract development and manufacturing deal with Emergent BioSolutions Inc. for its experimental COVID-19.....»»
Humanigen expands manufacturing partnership for COVID-19 candidate lenzilumab
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ocugen"s stock soars after company signs deal to co-develop Covid-19 vaccine candidate
Ocugen's stock price is up more than 90%.....»»
XpresSpa signs deal for COVID-19 testing facility at Salt Lake City airport
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA said it plans to issue emergency-use authorization to BioNTech-Pfizer COVID-19 vaccine
The Food and Drug Administration plans to finalize and issue an emergency-use authorization to BioNTech and Pfizer Inc.'s experimental COVID-19 vaccine, the regulator said Friday. Shares of BioNTech gained 1.5% in prema.....»»
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
Here's a roundup of top developments in the .....»»
Pfizer to outsource some drug production, focus on coronavirus vaccine
Pfizer Inc said on Friday it is in talks to shift more of its medicine production to outside contractors as it prepares for large-scale production of an experimental vaccine to prevent COVID-19, should it prove safe and effective......»»
FDA grants Gilead’s remdesivir emergency authorization for COVID-19 treatment
The Food and Drug Administration on Friday granted an emergency use authorization to Gilead Sciences Inc.’s remdesivir, a decade-old experimental therapy first tested on Ebola disease patients, as a COVID-19 treatment......»»
FDA clears Gilead"s emergency coronavirus treatment remdesivir
The Food and Drug Administration has authorized the emergency use of Gilead’s experimental drug remdesivir for COVID-19 treatment......»»
Gilead to work with partners to ramp up production of potential coronavirus treatment
Gilead Sciences Inc, maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment......»»
Gilead aims to expand remdesivir output for COVID-19, posts flat 1st-quarter results
Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment......»»
Gilead aims to expand remdesivir output for COVID-19, posts flat first-quarter results
Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday reported flat first-quarter earnings and said it with work with international partners to expand production of potential COVID-19 treatment......»»
FDA moving at "lightning speed" on Gilead drug
The Food and Drug Administration is moving at “lightning speed†to review data on Gilead Sciences Inc.’s experimental Covid-19 treatment remdesivir, Commissioner Stephen Hahn said, after encouraging results emerged from a key U.S. trial......»»
FDA moving at "lightning speed" on Gilead drug
The Food and Drug Administration is moving at “lightning speed†to review data on Gilead Sciences Inc.’s experimental Covid-19 treatment remdesivir, Commissioner Stephen Hahn said, after encouraging results emerged from a key U.S. trial......»»
Experimental drug remdesivir proves effective against COVID-19 in major study, US government officials announce
Gilead Sciences’s remdesivir would be the first treatment to pass such a test against th.....»»
Shares jump on coronavirus drug hopes, oil surges
World stock markets surged on Wednesday following encouraging news for an experimental COVID-19 treatment and some positive earnings reports, while beaten-up oil prices soared......»»
Shares jump after upbeat coronavirus drug data, oil surges
World stock markets surged on Wednesday following encouraging news for an experimental COVID-19 treatment and some positive earnings reports, while beaten-up oil prices surged......»»
Gilead reports early positive data in remdesivir studies as COVID-19 drug, though Chinese trial sees no benefit
Gilead Sciences Inc.’s experimental dr.....»»
Experimental drug remdesivir proved effective against COVID-19 in major study, drugmaker Gilead says
Gilead Sciences’s remdesivir would be the first treatment to pass such a test against th.....»»
Shares gain after encouraging COVID-19 drug data, oil jumps
A gauge of global stocks climbed on Wednesday following encouraging news for an experimental COVID-19 treatment and some positive earnings reports, while beaten-up oil prices surged......»»